Arifa Parker
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 3
- Tuberculosis Research and Epidemiology 2
-
- Long-Term Effects of COVID-19 6
- Co-authors
- Coenraad F.N. Koegelenberg (12 shared papers)Jantjie Taljaard (8 shared papers)Usha Lalla (9 shared papers)Brian Allwood (8 shared papers)Jeremy Nel (5 shared papers)Muhammad Moolla (8 shared papers)Hans Prozesky (5 shared papers)Elizabeth H. Louw (5 shared papers)
- Journals
- International Journal of Infectious Diseases (2 papers)Open Forum Infectious Diseases (2 papers)The Lancet Global Health (1 paper)BMJ Open (1 paper)African Journal of Primary Health Care & Family Medicine (1 paper)
- Partner nations
- South AfricaUnited KingdomUnited States
In The Last Decade
Arifa Parker
27 papers receiving 282 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 127
- Neurology 92
- Applied Microbiology and Biotechnology 10
- Critical Care and Intensive Care Medicine 20
- Microbiology 3
Countries citing papers authored by Arifa Parker
This map shows the geographic impact of Arifa Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arifa Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arifa Parker more than expected).
Fields of papers citing papers by Arifa Parker
This network shows the impact of papers produced by Arifa Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arifa Parker. The network helps show where Arifa Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Arifa Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 56 | |
| 2 | 2022 | 43 | |
| 3 | 2017 | 41 | |
| 4 | 2020 | 35 | |
| 5 | 2020 | 18 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2022 | 2 |
About Arifa Parker
Arifa Parker is a scholar working on Infectious Diseases, Neurology, Epidemiology, Surgery and Clinical Psychology, having authored 28 papers that have together received 291 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (6 papers), COVID-19 and Mental Health (3 papers), Antibiotic Use and Resistance (3 papers), COVID-19 Clinical Research Studies (3 papers), Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers), Infectious Diseases and Tuberculosis (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Infectious Diseases (127 citations), Neurology (92 citations), Applied Microbiology and Biotechnology (10 citations), Critical Care and Intensive Care Medicine (20 citations) and Microbiology (3 citations). Arifa Parker has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Coenraad F.N. Koegelenberg, Jantjie Taljaard, Usha Lalla, Brian Allwood, Jeremy Nel, Muhammad Moolla, Hans Prozesky, Elizabeth H. Louw, Natalie Mayet and Rubeshan Perumal. Their work appears in journals such as International Journal of Infectious Diseases, Open Forum Infectious Diseases, The Lancet Global Health, BMJ Open and African Journal of Primary Health Care & Family Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.